NASDAQ Biotechnology Total Retu XNBI Indice
4634.38 USD
{{ price }}
-0.854900%
{{change_pct}}%
PAYS
États-Unis
Marché
Nasdaq GIDS
Plus Haut - Plus Bas [24H]
4632.45
-
4704.03 USD
Nombre de composants
190
NASDAQ Biotechnology Total Retu Graphique des prix
Top 5 Gagnants au Cours des Dernières 24 Heures
| CRIS | Curis | +11.55% | |
|---|---|---|---|
| EGRX | Eagle Pharmaceuticals | +9.52% | |
| INSM | Insmed Incorporated | +7.75% | |
| ENTA | Enanta Pharmaceuticals | +4.88% | |
| INCR | InterCure | +4.66% |
Top 5 Perdants au Cours des Dernières 24 Heures
| NKTR | Nektar Therapeutics | -15.86% | |
|---|---|---|---|
| IRWD | Ironwood Pharmaceuticals | -9.69% | |
| AKBA | Akebia Therapeutics | -8.93% | |
| OMER | Omeros | -6.7% | |
| INO | Inovio Pharmaceuticals | -5.78% |
NASDAQ Biotechnology Total Retu XNBI APERÇU FINANCIER ET COMMERCIAL
| NASDAQ Biotechnology Total Retu Prix de l'Indice | 4634.38 USD |
| Dernière clôture | 4472.96 USD |
| Ouverture | 4476.26 USD |
| Offre | 0 USD x 0 |
| Demande | 0 USD x 0 |
| Variation du jour | 4464.53 - 4532.84 USD |
| Plage sur 52 semaines | 4464.53 - 4532.84 USD |
| Volume | 0 USD |
| Volume moyen | N/A |
Informations de trading
NASDAQ Biotechnology Total Retu Historique des prix de l'Indice
| Plus haut sur 52 semaines | 4532.84 USD |
| Plus bas sur 52 semaines | 4464.53 USD |
| Moyenne mobile sur 50 jours | N/A |
| Moyenne mobile sur 200 jours | N/A |
XNBI Statistiques de l'indice
| Volume moyen (3 mois) | N/A |
| Volume journalier moyen (10 jours) | N/A |
Questions et réponses concernant l'indice NASDAQ Biotechnology Total Retu
Quel est le cours actuel de l'Indice XNBI ?
Le prix de l'Indice NASDAQ Biotechnology Total Retu XNBI aujourd'hui est de 4634.38 USD.
Comment acheter l'Indice NASDAQ Biotechnology Total Retu ?
Vous pouvez acheter l'indice XNBI sur la plateforme Nasdaq GIDS. Contactez votre conseiller financier pour choisir un courtier.
Quel est le symbole boursier de l'Indice NASDAQ Biotechnology Total Retu ?
Le symbole boursier ou ticker de l'Indice NASDAQ Biotechnology Total Retu est XNBI.
Combien de composants contient l'Indice NASDAQ Biotechnology Total Retu ?
L'Indice NASDAQ Biotechnology Total Retu contient 190 composants.
À quel pays appartient l'Indice NASDAQ Biotechnology Total Retu ?
L'Indice NASDAQ Biotechnology Total Retu fait référence à United States.
À quelle bourse appartient l'Indice NASDAQ Biotechnology Total Retu ?
L'Indice NASDAQ Biotechnology Total Retu fait référence à la bourse Nasdaq GIDS.
NASDAQ Biotechnology Total Retu COMPOSANTS
| Nom Nom | Prix Prix |
24h% 7j Graphique 24h%&7j |
Cap. du marché Cap. du marché | VOL Volume | 24h bas | 24h de haut | Cap. du marché | PER | BPA |
|---|
| Nom Nom | Prix Prix |
24h% 7j Graphique 24h%&7j |
Cap. du marché Cap. du marché | VOL Volume | 24h bas | 24h de haut | Cap. du marché | PER | BPA |
|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} |
| Amgen AMGN | $291.81 — |
-0.55
|
$156.91B — | $1.71M — | $291.18 — | $294.63 — | $156.91B — | 26.31 | $11.09 — |
| Gilead Sciences GILD | $109.3 — |
-0.72
|
$135.96B — | $6.39M — | $109.04 — | $111.04 — | $135.96B — | 23.15 | $4.72 — |
| Vertex Pharmaceuticals Incorporated VRTX | $452.44 — |
+0.2
|
$116.19B — | $847.98K — | $450.13 — | $460.33 — | $116.19B — | 0 | -$3.85 — |
| Regeneron Pharmaceuticals REGN | $518.6 — |
-0.94
|
$55.99B — | $938.96K — | $516.29 — | $528.37 — | $55.99B — | 13.31 | $38.95 — |
| Seagen SGEN | $228.74 — |
0
|
$43.15B — | $0 — | $0 — | $0 — | $43.15B — | 0 | $0 — |
| Alnylam Pharmaceuticals ALNY | $298.58 — |
-1.28
|
$38.93B — | $443.95K — | $298.25 — | $303.35 — | $38.93B — | 0 | -$2.06 — |
| Biogen BIIB | $133.06 — |
-1.79
|
$19.5B — | $1.33M — | $132.9 — | $136.41 — | $19.5B — | 13.38 | $9.94 — |
| Insmed Incorporated INSM | $97.98 — |
+7.75
|
$17.85B — | $12.56M — | $90.93 — | $98.95 — | $17.85B — | 0 | -$6.39 — |
| Illumina ILMN | $87.54 — |
-0.5
|
$13.86B — | $2.24M — | $87.17 — | $90.11 — | $13.86B — | 0 | -$6.05 — |
| Incyte INCY | $68.85 — |
-1.74
|
$13.33B — | $2.1M — | $68.79 — | $70.35 — | $13.33B — | 344.25 | $0.2 — |
| United Therapeutics UTHR | $276.47 — |
-1.74
|
$12.47B — | $1.45M — | $274.06 — | $288.55 — | $12.47B — | 11.21 | $24.66 — |
| Neurocrine Biosciences NBIX | $124.17 — |
-0.48
|
$12.29B — | $887.08K — | $123.97 — | $125.51 — | $12.29B — | 42.37 | $2.93 — |
| Exelixis EXEL | $41.43 — |
-2.56
|
$11.3B — | $3.15M — | $41.31 — | $42.65 — | $11.3B — | 19.45 | $2.13 — |
| BioMarin Pharmaceutical BMRN | $57.16 — |
-0.56
|
$10.96B — | $1.85M — | $57.02 — | $57.99 — | $10.96B — | 21.24 | $2.69 — |
| Qiagen QGEN | $46.72 — |
+1.08
|
$10.12B — | $1.44M — | $46.62 — | $47.23 — | $10.12B — | 108.65 | $0.43 — |
| ImmunoGen IMGN | $31.23 — |
0
|
$8.72B — | $0 — | $0 — | $0 — | $8.72B — | 0 | $0 — |
| Blueprint Medicines BPMC | $127.95 — |
-0.02
|
$8.27B — | $3.82M — | $127.84 — | $128.34 — | $8.27B — | 0 | -$2.51 — |
| Bio-Techne TECH | $51.54 — |
+0.27
|
$8.08B — | $2.7M — | $51.15 — | $52.82 — | $8.08B — | 62.09 | $0.83 — |
| Repligen RGEN | $132 — |
-0.65
|
$7.42B — | $474.75K — | $130.81 — | $135.3 — | $7.42B — | 0 | -$0.42 — |
| Grifols, S.A. GRFS | $8.95 — |
-0.78
|
$7.37B — | $423.36K — | $8.92 — | $9.08 — | $7.37B — | 34.42 | $0.26 — |
- {{ link.label }} {{link}}